We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Belluscura Plc (BELL) ORD GBP0.01

Sell:9.50p Buy:11.00p 0 Change: No change
Market closed |  Prices as at close on 14 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.50p
Buy:11.00p
Change: No change
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 14 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.50p
Buy:11.00p
Change: No change
Market closed |  Prices as at close on 14 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

Contact details

Address:
15 Fetter Lane
LONDON
EC4A 1BW
United Kingdom
Telephone:
+1 (0214) 3968313
Website:
https://www.belluscura.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 02 April 2024 02/04/24
General meeting 05 February 2024 05/02/24
Trading Announcement 20 December 2023 20/12/23
AGM 14 September 2023 14/09/23
Interim results 13 September 2023 13/09/23
Final results 29 June 2023 29/06/23
General meeting 14 June 2023 14/06/23

General stock information

EPIC:
BELL
ISIN:
GB00BD3B8Z11
Market cap:
£16.92 million
Shares in issue:
165.03 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Robert Rauker
    Chief Executive Officer, Director
  • Simon Neicheril
    Chief Financial Officer, Director
  • Robert Fary
    Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.